Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation?

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 3, 2010, Pages 367-374

  Sobor, Melinda ^a,b   Timár, Julia ^b   Riba, Pal ^b   Király, Kornél P ^b   Gyarmati, Susanna ^b   Al Khrasani, Mahmoud ^b   Fürst, Susanna ^b,c  

^a Orszagos Gyogyszereszeti Intezet   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Antinociception; Chronic morphine; Lactation; Maternal behaviour; Morphine challenge; Pregnancy; Rat; Retrieval test

Indexed keywords

MORPHINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; EUPHORIA; FEMALE; LACTATION; LITTER SIZE; MATERNAL BEHAVIOR; MORNING DOSAGE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RAT; SENSITIZATION; TAIL FLICK TEST; ANIMAL; BREEDING; COMPARATIVE STUDY; DRUG EFFECTS; MALE; PHYSIOLOGY; PSYCHOLOGY; TIME; WISTAR RAT;

ANIMALS; FEMALE; LACTATION; MALE; MATERNAL BEHAVIOR; MORPHINE; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, WISTAR; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 77950459875     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.02.015     Document Type: Article

References (44)

1. Aasmundstad T.A., Morland J., Paulsen R.E. Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. J Pharmacol Exp Ther 1995, 275:435-441.
2. Al-Khrasani M., Spetea M., Friedmann T., Riba P., Kiraly K., Schmidhammer H., et al. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens. Brain Res Bull 2007, 74:369-375.
3. Blass E.M., Shide D.J., Zaw-Mon C., Sorrentino J. Mother as shield: differential effects of contact and nursing on pain responsivity in infant rats-evidence for nonopioid mediation. Behav Neurosci 1995, 109:342-353.
4. Bridges R.S., Grimm C.T. Reversal of morphine disruption of maternal behavior by concurrent treatment with the opiate antagonist naloxone. Science 1982, 218:166-168.
5. Brunton P.J., Russell J.A. The expectant brain: adapting for motherhood. Nat Rev 2008, 9:11-25.
6. Buckett W.R. Some pharmacological studies with 14-cinnamoyloxycodeinone. J Pharm Pharmacol 1965, 17:759-760.
7. Carpenter M.J., Chutuape M.A., Stitzer M.L. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend 1998, 53:11-15.
8. Cheek F.E., Holstein C.N., Fullam F.A., Arana G., Tomarchio T.P., Mandell S. From heroin to methadone-social role changes and reinforcement differentials in relation to outcome on methadone. Part I. The study of reinforcement differentials. Int J Addict 1976, 11:659-679.
9. Crawford G.A., Washington M.C., Senay E.C. Careers with heroin. Int J Addict 1983, 18:701-715.
10. Degenhardt L., Kinner S.A., Roxburgh A., Black E., Bruno R., Fetherston J., et al. Drug use and risk among regular injecting drug users in Australia: does age make a difference?. Drug Alcohol Rev 2008, 27:357-360.
11. Dumas E.O., Pollack G.M. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J 2008, 10:537-551.
12. Freye E., Latasch L. Development of opioid tolerance - molecular mechanisms and clinical consequences. Anasthesiol Intensivmed Notfallmed Schmerzther 2003, 38:14-26.
13. Furst Z. Central and peripheral mechanisms in antinociception: current and future perspectives. Neuropsychopharmacol Hung 2008, 10:127-130.
14. Furst Z., Buzas B., Friedmann T., Schmidhammer H., Borsodi A. Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series. Eur J Pharmacol 1993, 236:209-215.
15. Gagin R., Cohen E., Shavit Y. Prenatal exposure to morphine alters analgesic responses and preference for sweet solutions in adult rats. Pharmacol Biochem Behav 1996, 55:629-634.
16. Gagin R., Kook N., Cohen E., Shavit Y. Prenatal morphine enhances morphine-conditioned place preference in adult rats. Pharmacol Biochem Behav 1997, 58:525-528.
17. Grimm C.T., Bridges R.S. Opiate regulation of maternal behavior in the rat. Pharmacol Biochem Behav 1983, 19:609-616.
18. Hammer R.P., Bridges R.S. Preoptic area opioids and opiate receptors increase during pregnancy and decrease during lactation. Brain Res 1987, 420:48-56.
19. Handelsman L., Aronson M.J., Ness R., Cochrane K.J., Kanof P.D. The dysphoria of heroin addiction. Am J Drug Alcohol Abuse 1992, 18:275-287.
20. Hosztafi S. Heroin, part III: the pharmacology of heroin. Acta Pharm Hung 2003, 73:197-205.
21. Hutcheson D.M., Everitt B.J., Robbins T.W., Dickinson A. The role of withdrawal in heroin addiction: enhances reward or promotes avoidance?. Nat Neurosci 2001, 4:943-947.
22. Hutchings D.E., Zmitrovich A., Church S., Malowany D. Methadone during pregnancy: the search for a valid animal model. Ann Ist Super Sanita 1993, 29:439-444.
23. Kanjhan R. Opioids and pain. Clin Exp Pharmacol Physiol 1995, 22:397-403.
24. Kinsley C.H., Bridges R.S. Parity-associated reductions in behavioral sensitivity to opiates. Biol Reprod 1988, 39:270-278.
25. Kinsley C.H., Wellman J.C., Carr D.B., Graham A. Opioid regulation of parental behavior in juvenile rats. Pharmacol Biochem Behav 1993, 44:763-768.
26. Kiraly K.P., Riba P., D'Addario C., Di Benedetto M., Landuzzi D., Candeletti S., et al. Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime. Brain Res Bull 2006, 70:233-239.
27. Mann P.E., Kinsley C.H., Bridges R.S. Opioid receptor subtype involvement in maternal behavior in lactating rats. Neuroendocrinology 1991, 53:487-492.
28. Mayer A.D., Faris P.L., Komisaruk B.R., Rosenblatt J.S. Opiate antagonism reduces placentophagia and pup cleaning by parturient rats. Pharmacol Biochem Behav 1985, 22:1035-1044.
29. Miranda-Paiva C.M., Nasello A.G., Yin A.J., Felicio L.F. Morphine pretreatment increases opioid inhibitory effects on maternal behavior. Brain Res Bull 2001, 55:501-505.
30. Myers M.M., Brunelli S.A., Squire J.M., Shindeldecker R.D., Hofer M.A. Maternal behavior of SHR rats and its relationship to offspring blood pressures. Dev Psychobiol 1989, 22:29-53.
31. Okura T., Komiyama N., Morita Y., Kimura M., Deguchi Y., Yamada S. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats. Life Sci 2007, 80:1319-1326.
32. Ramsey N.F., Niesink R.J., Van Ree J.M. Prenatal exposure to morphine enhances cocaine and heroin self-administration in drug-naive rats. Drug Alcohol Depend 1993, 33:41-51.
33. Rayner V.C., Robinson I.C., Russell J.A. Chronic intracerebroventricular morphine and lactation in rats: dependence and tolerance in relation to oxytocin neurones. J Physiol 1988, 396:319-347.
34. Riba P., Ben Y., Nguyen T.M., Furst S., Schiller P.W., Lee N.M. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine. Curr Med Chem 2002, 9:31-39.
35. Riba P., Ben Y., Smith A.P., Furst S., Lee N.M. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors. J Pharmacol Exp Ther 2002, 300:265-272.
36. Rosenblatt J.S., Mayer A.D., Giordano A.L. Hormonal basis during pregnancy for the onset of maternal behavior in the rat. Psychoneuroendocrinology 1988, 13:29-46.
37. Sherman J.E., Zinser M.C., Sideroff S.I., Baker T.B. Subjective dimensions of heroin urges: influence of heroin-related and affectively negative stimuli. Addict Behav 1989, 14:611-623.
38. Shimoyama M., Shimoyama N., Zhao G.M., Schiller P.W., Szeto H.H. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA. J Pharmacol Exp Ther 2001, 297:364-371.
39. Slamberova R., Szilagyi B., Vathy I. Repeated morphine administration during pregnancy attenuates maternal behavior. Psychoneuroendocrinology 2001, 26:565-576.
40. Stain F., Barjavel M.J., Sandouk P., Plotkine M., Scherrmann J.M., Bhargava H.N. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat. J Pharmacol Exp Ther 1995, 274:852-857.
41. Tenconi B., Lesma E., DiGiulio A.M., Gorio A. High opioid doses inhibit whereas low doses enhance neuritogenesis in PC12 cells. Brain Res 1996, 94:175-181.
42. Timár J., Sobor M., Király K.P., Gyarmati S., Riba P., Al-Khrasani M., et al. Peri, pre and postnatal morphine exposure: exposure-induced effects and sex differences in the behavioural consequences in rat offspring. Behav Pharmacol 2010, 21:58-68.
43. Yang S.N., Huang L.T., Wang C.L., Chen W.F., Yang C.H., Lin S.Z., et al. Prenatal administration of morphine decreases CREBSerine-133 phosphorylation and synaptic plasticity range mediated by glutamatergic transmission in the hippocampal CA1 area of cognitive-deficient rat offspring. Hippocampus 2003, 13:915-921.
44. Yim A.J., Miranda-Paiva C.M., Florio J.C., Oliveira C.A., Nasello A.G., Felicio L.F. A comparative study of morphine treatment regimen prior to mating and during late pregnancy. Brain Res Bull 2006, 68:384-391.